Joincare Pharmaceutical Group Industry Co Ltd (600380) - Net Assets

Latest as of March 2026: CN¥24.53 Billion CNY ≈ $3.59 Billion USD

Based on the latest financial reports, Joincare Pharmaceutical Group Industry Co Ltd (600380) has net assets worth CN¥24.53 Billion CNY (≈ $3.59 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥35.48 Billion ≈ $5.19 Billion USD) and total liabilities (CN¥10.95 Billion ≈ $1.60 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Joincare Pharmaceutical Group Industry C (600380) total assets for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥24.53 Billion
% of Total Assets	69.14%
Annual Growth Rate	21.28%
5-Year Change	20.76%
10-Year Change	161.05%
Growth Volatility	122.4

Joincare Pharmaceutical Group Industry Co Ltd - Net Assets Trend (1997–2025)

This chart illustrates how Joincare Pharmaceutical Group Industry Co Ltd's net assets have evolved over time, based on quarterly financial data. Check Joincare Pharmaceutical Group Industry C (600380) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Joincare Pharmaceutical Group Industry Co Ltd (1997–2025)

The table below shows the annual net assets of Joincare Pharmaceutical Group Industry Co Ltd from 1997 to 2025. For live valuation and market cap data, see how much is Joincare Pharmaceutical Group Industry C worth.

Year	Net Assets	Change
2025-12-31	CN¥24.37 Billion ≈ $3.57 Billion	+4.14%
2024-12-31	CN¥23.40 Billion ≈ $3.42 Billion	+3.36%
2023-12-31	CN¥22.64 Billion ≈ $3.31 Billion	+2.81%
2022-12-31	CN¥22.02 Billion ≈ $3.22 Billion	+9.12%
2021-12-31	CN¥20.18 Billion ≈ $2.95 Billion	+4.90%
2020-12-31	CN¥19.24 Billion ≈ $2.81 Billion	+10.66%
2019-12-31	CN¥17.38 Billion ≈ $2.54 Billion	+6.67%
2018-12-31	CN¥16.30 Billion ≈ $2.38 Billion	+19.67%
2017-12-31	CN¥13.62 Billion ≈ $1.99 Billion	+45.88%
2016-12-31	CN¥9.33 Billion ≈ $1.37 Billion	+27.75%
2015-12-31	CN¥7.31 Billion ≈ $1.07 Billion	+11.70%
2014-12-31	CN¥6.54 Billion ≈ $957.23 Million	+8.59%
2013-12-31	CN¥6.02 Billion ≈ $881.55 Million	+7.76%
2012-12-31	CN¥5.59 Billion ≈ $818.10 Million	+2.40%
2011-12-31	CN¥5.46 Billion ≈ $798.94 Million	+2.68%
2010-12-31	CN¥5.32 Billion ≈ $778.05 Million	+20.79%
2009-12-31	CN¥4.40 Billion ≈ $644.12 Million	+13.98%
2008-12-31	CN¥3.86 Billion ≈ $565.10 Million	-5.13%
2007-12-31	CN¥4.07 Billion ≈ $595.64 Million	+41.23%
2006-12-31	CN¥2.88 Billion ≈ $421.74 Million	-4.83%
2005-12-31	CN¥3.03 Billion ≈ $443.13 Million	+1.87%
2004-12-31	CN¥2.97 Billion ≈ $434.97 Million	-1.98%
2003-12-31	CN¥3.03 Billion ≈ $443.74 Million	+50.73%
2002-12-31	CN¥2.01 Billion ≈ $294.39 Million	+1.55%
2001-12-31	CN¥1.98 Billion ≈ $289.91 Million	+668.64%
2000-12-31	CN¥257.75 Million ≈ $37.72 Million	+35.73%
1999-12-31	CN¥189.89 Million ≈ $27.79 Million	+35.06%
1998-12-31	CN¥140.59 Million ≈ $20.57 Million	+28.06%
1997-12-31	CN¥109.79 Million ≈ $16.07 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Joincare Pharmaceutical Group Industry Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 44559.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥11.40 Billion	75.12%
Other Components	CN¥3.78 Billion	24.88%
Total Equity	CN¥15.18 Billion	100.00%

Joincare Pharmaceutical Group Industry Co Ltd Competitors by Market Cap

The table below lists competitors of Joincare Pharmaceutical Group Industry Co Ltd ranked by their market capitalization.

Company	Market Cap
Beijing Haohua Energy Resource Co Ltd SHG:601101	$2.68 Billion
Vapores SN:VAPORES	$2.68 Billion
Air France-KLM SA PA:AF	$2.68 Billion
Seadrill Limited NYSE:SDRL	$2.68 Billion
Worthington Industries Inc NYSE:WOR	$2.68 Billion
CREDITACCESS GRAMEEN LIMITED NSE:CREDITACC	$2.68 Billion
Ratch Group Public Company Limited BK:RATCH	$2.68 Billion
Brookfield Wealth Solutions Ltd. NYSE:BNT	$2.68 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Joincare Pharmaceutical Group Industry Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 14,534,720,000 to 15,179,567,286, a change of 644,847,286 (4.4%).
Net income of 1,335,547,731 contributed positively to equity growth.
Dividend payments of 447,069,886 reduced retained earnings.
Other comprehensive income decreased equity by 1,321,684,000.
Other factors increased equity by 1,078,053,442.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥1.34 Billion	+8.8%
Dividends Paid	CN¥447.07 Million	-2.95%
Other Comprehensive Income	CN¥-1.32 Billion	-8.71%
Other Changes	CN¥1.08 Billion	+7.1%
Total Change	CN¥-	4.44%

Book Value vs Market Value Analysis

This analysis compares Joincare Pharmaceutical Group Industry Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.21x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 156.66x to 1.21x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1997-12-31	CN¥0.06	CN¥10.01	x
1998-12-31	CN¥0.05	CN¥10.01	x
1999-12-31	CN¥0.11	CN¥10.01	x
2000-12-31	CN¥0.15	CN¥10.01	x
2001-12-31	CN¥1.15	CN¥10.01	x
2002-12-31	CN¥1.17	CN¥10.01	x
2003-12-31	CN¥1.24	CN¥10.01	x
2004-12-31	CN¥1.20	CN¥10.01	x
2005-12-31	CN¥1.23	CN¥10.01	x
2006-12-31	CN¥1.12	CN¥10.01	x
2007-12-31	CN¥1.66	CN¥10.01	x
2008-12-31	CN¥1.59	CN¥10.01	x
2009-12-31	CN¥1.79	CN¥10.01	x
2010-12-31	CN¥2.20	CN¥10.01	x
2011-12-31	CN¥2.20	CN¥10.01	x
2012-12-31	CN¥2.27	CN¥10.01	x
2013-12-31	CN¥2.39	CN¥10.01	x
2014-12-31	CN¥2.55	CN¥10.01	x
2015-12-31	CN¥2.72	CN¥10.01	x
2016-12-31	CN¥3.12	CN¥10.01	x
2017-12-31	CN¥4.71	CN¥10.01	x
2018-12-31	CN¥5.91	CN¥10.01	x
2019-12-31	CN¥5.33	CN¥10.01	x
2020-12-31	CN¥5.67	CN¥10.01	x
2021-12-31	CN¥6.10	CN¥10.01	x
2022-12-31	CN¥6.92	CN¥10.01	x
2023-12-31	CN¥7.25	CN¥10.01	x
2024-12-31	CN¥7.76	CN¥10.01	x
2025-12-31	CN¥8.30	CN¥10.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Joincare Pharmaceutical Group Industry Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 8.80%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 8.78%
• Asset Turnover: 0.43x
• Equity Multiplier: 2.33x
Recent ROE (8.80%) is below the historical average (16.26%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1997	77.24%	26.79%	0.71x	4.09x	CN¥73.83 Million
1998	63.60%	15.01%	0.66x	6.44x	CN¥49.40 Million
1999	28.04%	10.92%	0.71x	3.59x	CN¥34.26 Million
2000	60.52%	23.02%	0.89x	2.95x	CN¥130.22 Million
2001	10.13%	29.55%	0.29x	1.17x	CN¥2.50 Million
2002	8.56%	24.15%	0.28x	1.26x	CN¥-28.82 Million
2003	6.60%	8.00%	0.40x	2.08x	CN¥-72.24 Million
2004	4.72%	4.15%	0.53x	2.14x	CN¥-108.86 Million
2005	6.05%	5.14%	0.57x	2.08x	CN¥-83.62 Million
2006	-2.49%	-2.20%	0.46x	2.49x	CN¥-238.22 Million
2007	25.02%	29.02%	0.42x	2.08x	CN¥435.29 Million
2008	-0.97%	-0.92%	0.50x	2.10x	CN¥-304.75 Million
2009	15.57%	13.20%	0.60x	1.97x	CN¥173.87 Million
2010	19.29%	16.55%	0.63x	1.85x	CN¥356.47 Million
2011	6.91%	5.47%	0.54x	2.33x	CN¥-117.13 Million
2012	4.38%	2.90%	0.60x	2.52x	CN¥-217.88 Million
2013	6.70%	4.40%	0.58x	2.63x	CN¥-134.75 Million
2014	8.14%	4.78%	0.61x	2.78x	CN¥-81.07 Million
2015	8.77%	4.77%	0.63x	2.93x	CN¥-57.99 Million
2016	8.39%	4.64%	0.60x	2.99x	CN¥-86.87 Million
2017	28.88%	19.79%	0.49x	3.01x	CN¥1.39 Billion
2018	7.25%	6.24%	0.45x	2.59x	CN¥-264.94 Million
2019	8.64%	7.47%	0.47x	2.46x	CN¥-141.25 Million
2020	10.10%	8.29%	0.48x	2.54x	CN¥10.83 Million
2021	11.24%	8.35%	0.51x	2.63x	CN¥146.47 Million
2022	11.45%	8.77%	0.48x	2.72x	CN¥190.60 Million
2023	10.49%	8.67%	0.46x	2.64x	CN¥67.19 Million
2024	9.54%	8.88%	0.44x	2.46x	CN¥-66.90 Million
2025	8.80%	8.78%	0.43x	2.33x	CN¥-182.41 Million

Industry Comparison

This section compares Joincare Pharmaceutical Group Industry Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $2,133,881,544
Average return on equity (ROE) among peers: 2.68%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Joincare Pharmaceutical Group Industry Co Ltd (600380)	CN¥24.53 Billion	77.24%	0.45x	$2.68 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$868.76 Million	4.89%	3.05x	$639.13 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$775.01 Million	2.45%	0.87x	$378.07 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$10.33 Billion	15.07%	0.27x	$5.07 Billion
Livzon Pharmaceutical Group Inc (000513)	$662.32 Million	12.10%	0.68x	$2.59 Billion
Wedge Industrial Co Ltd (000534)	$692.08 Million	2.78%	1.05x	$1.97 Billion
Yunnan Baiyao Group Co Ltd (000538)	$3.19 Billion	14.61%	0.55x	$13.23 Billion
Hainan Haiyao Co Ltd (000566)	$1.49 Billion	5.19%	0.85x	$1.11 Billion
Tus Pharmaceutical Group Co Ltd (000590)	$231.22 Million	-38.13%	1.23x	$302.41 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$1.75 Billion	0.46%	2.42x	$956.43 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$1.35 Billion	7.34%	0.44x	$3.16 Billion

About Joincare Pharmaceutical Group Industry Co Ltd

SHG:600380 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.68 Billion

CN¥18.31 Billion CNY

Market Cap Rank

#5254 Global

#928 in China

Share Price

CN¥10.01

Change (1 day)

-0.99%

52-Week Range

CN¥9.29 - CN¥13.66

All Time High

CN¥20.78